Literature DB >> 32145863

Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement on Heart Transplantation: Patient Eligibility, Selection, and Post-Transplantation Care.

Sharon Chih1, Michael McDonald2, Anne Dipchand3, Daniel Kim4, Anique Ducharme5, Annemarie Kaan6, Susan Abbey7, Mustafa Toma8, Kim Anderson9, Ryan Davey10, Lisa Mielniczuk11, Patricia Campbell4, Shelley Zieroth12, Christine Bourgault13, Mitesh Badiwala14, Brian Clarke15, Eric Belanger16, Michel Carrier17, Jennifer Conway18, Karen Doucette4, Nadia Giannetti19, Debra Isaac15, Rod MacArthur4, Mario Senechal20.   

Abstract

Significant practice-changing developments have occurred in the care of heart transplantation candidates and recipients over the past decade. This Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement provides evidence-based, expert panel recommendations with values and preferences, and practical tips on: (1) patient selection criteria; (2) selected patient populations; and (3) post transplantation surveillance. The recommendations were developed through systematic review of the literature and using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. The evolving areas of importance addressed include transplant recipient age, frailty assessment, pulmonary hypertension evaluation, cannabis use, combined heart and other solid organ transplantation, adult congenital heart disease, cardiac amyloidosis, high sensitization, and post-transplantation management of antibodies to human leukocyte antigen, rejection, cardiac allograft vasculopathy, and long-term noncardiac care. Attention is also given to Canadian-specific management strategies including the prioritization of highly sensitized transplant candidates (status 4S) and heart organ allocation algorithms. The focus topics in this position statement highlight the increased complexity of patients who undergo evaluation for heart transplantation as well as improved patient selection, and advances in post-transplantation management and surveillance that have led to better long-term outcomes for heart transplant recipients.
Copyright © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32145863     DOI: 10.1016/j.cjca.2019.12.025

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  5 in total

Review 1.  The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences.

Authors:  C Sciaccaluga; N Ghionzoli; G E Mandoli; N Sisti; F D'Ascenzi; M Focardi; S Bernazzali; G Vergaro; M Emdin; S Valente; M Cameli
Journal:  Heart Fail Rev       Date:  2021-08-12       Impact factor: 4.654

2.  Heart transplantation in amyloidosis. Clinical and imaging manifestations

Authors:  Santiago Decotto; Eugenia Villanueva; Diego Pérez de Arenaza; Elsa M Nucifora; María A Aguirre; María L Posadas-Martínez; Ricardo G Marenchino; César A Belziti
Journal:  Arch Cardiol Mex       Date:  2022-07-01

Review 3.  Congestive Hepatopathy.

Authors:  José Ignacio Fortea; Ángela Puente; Antonio Cuadrado; Patricia Huelin; Raúl Pellón; Francisco José González Sánchez; Marta Mayorga; María Luisa Cagigal; Inés García Carrera; Marina Cobreros; Javier Crespo; Emilio Fábrega
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

4.  National Trends of Gender Disparity in Canadian Cardiovascular Society Guideline Authors, 2001-2020.

Authors:  Devesh Rai; Syed Hamza Waheed; Miranda Guerriero; Muhammad Waqas Tahir; Ritambhara Pandey; Harsh Patel; Samarthkumar Thakkar; Sharon L Mulvagh; Alexandra Bastiany; Shelley Zieroth; Colleen M Norris; Harriette G C Van Spall; Erin D Michos; Martha Gulati
Journal:  CJC Open       Date:  2021-04-10

5.  Low-Density Lipoprotein Cholesterol Level Trends and the Development of Cardiac Allograft Vasculopathy After Heart Transplantation.

Authors:  Natasha Aleksova; Fraz Umar; Jordan Bernick; Lisa M Mielniczuk; Heather J Ross; Sharon Chih
Journal:  CJC Open       Date:  2021-07-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.